{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:55:59Z","timestamp":1788195359921,"version":"build-2803163510"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12026-023-09371-7","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T22:01:25Z","timestamp":1686780085000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["COVID-19 infection: a possible induction factor for development of autoimmune diseases?"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-4408","authenticated-orcid":false,"given":"Nikoo","family":"Saeedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes Sadat Farizani","family":"Gohari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ali Moodi","family":"Ghalibaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Bagher","family":"Owlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"issue":"5","key":"9371_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3390\/ijerph17051729","volume":"17","author":"C Wang","year":"2020","unstructured":"Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5):1729.","journal-title":"Int J Environ Res Public Health"},{"key":"9371_CR2","doi-asserted-by":"crossref","unstructured":"Mahase E. China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ Brit Med J (Online). 2020;368.","DOI":"10.1136\/bmj.m408"},{"key":"9371_CR3","doi-asserted-by":"crossref","unstructured":"Thienemann F, Pinto F, Grobbee DE, Boehm M, Bazargani N, Ge J, et al. World heart federation briefing on prevention: Coronavirus disease 2019 (COVID-19) in low-income countries. Global Heart. 2020;15(1).","DOI":"10.5334\/gh.778"},{"issue":"10","key":"9371_CR4","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1080\/21645515.2020.1799669","volume":"16","author":"M Rokni","year":"2020","unstructured":"Rokni M, Hamblin MR, Rezaei N. Cytokines and COVID-19: Friends or foes? Hum Vaccin Immunother. 2020;16(10):2363\u20135.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"9371_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/JLB.5MR0120-218RRR","volume":"108","author":"AL Chetaille N\u00e9zondet","year":"2020","unstructured":"Chetaille N\u00e9zondet AL, Poubelle PE, Pelletier M. The evaluation of cytokines to help establish diagnosis and guide treatment of autoinflammatory and autoimmune diseases. J Leukoc Biol. 2020;108(2):647\u201357.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"9371_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/imr.12091","volume":"255","author":"DR Getts","year":"2013","unstructured":"Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev. 2013;255(1):197\u2013209.","journal-title":"Immunol Rev"},{"issue":"8","key":"9371_CR7","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"9371_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846\u20138.","journal-title":"Intensive Care Med"},{"issue":"1","key":"9371_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","volume":"108","author":"J Wang","year":"2020","unstructured":"Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020;108(1):17\u201341.","journal-title":"J Leukoc Biol"},{"key":"9371_CR10","doi-asserted-by":"publisher","first-page":"102506","DOI":"10.1016\/j.jaut.2020.102506","volume":"114","author":"Y Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020;114:102506.","journal-title":"J Autoimmun"},{"key":"9371_CR11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm: What we know so far. Front Immunol. 2020;11:1446.","journal-title":"Front Immunol"},{"issue":"10229","key":"9371_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet"},{"issue":"6","key":"9371_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"9371_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/1040841X.2019.1614904","volume":"45","author":"HM Hussein","year":"2019","unstructured":"Hussein HM, Rahal EA. The role of viral infections in the development of autoimmune diseases. Crit Rev Microbiol. 2019;45(4):394\u2013412.","journal-title":"Crit Rev Microbiol"},{"issue":"6","key":"9371_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.27421","volume":"62","author":"JB Harley","year":"2010","unstructured":"Harley JB, James JA. Everyone comes from somewhere: Systemic lupus erythematosus and Epstein-Barr virus induction of host interferon and humoral anti-Epstein-Barr nuclear antigen 1 immunity. Arthritis Rheum. 2010;62(6):1571\u20135.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9371_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","volume":"78","author":"NR Jog","year":"2019","unstructured":"Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, et al. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis. 2019;78(9):1235\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"9371_CR17","doi-asserted-by":"publisher","first-page":"102556","DOI":"10.1016\/j.autrev.2020.102556","volume":"19","author":"G Lucchese","year":"2020","unstructured":"Lucchese G, Fl\u00f6el A. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev. 2020;19(7):102556.","journal-title":"Autoimmun Rev"},{"key":"9371_CR18","doi-asserted-by":"crossref","unstructured":"Marino Gammazza A, L\u00e9gar\u00e9 S, Lo Bosco G, Fucarino A, Angileri F, Conway de Macario E, et al. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: Possible role of molecular mimicry in COVID-19. Cell Stress Chaperones. 2020;25(5):737\u201341.","DOI":"10.1007\/s12192-020-01148-3"},{"issue":"5","key":"9371_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","volume":"25","author":"G Lucchese","year":"2020","unstructured":"Lucchese G, Fl\u00f6el A. SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: Molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020;25(5):731\u20135.","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"9371_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41420-020-00321-y","volume":"6","author":"AJ Venkatakrishnan","year":"2020","unstructured":"Venkatakrishnan AJ, Kayal N, Anand P, Badley AD, Church GM, Soundararajan V. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2. Cell Death Discov. 2020;6(1):96.","journal-title":"Cell Death Discov"},{"key":"9371_CR21","doi-asserted-by":"crossref","unstructured":"Kanduc D. From anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry. Antibodies. 2020;9(3):33\u20138.","DOI":"10.3390\/antib9030033"},{"issue":"2","key":"9371_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nm.4044","volume":"22","author":"S Muller","year":"2016","unstructured":"Muller S, Radic M. Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus. Nat Med. 2016;22(2):126\u20137.","journal-title":"Nat Med"},{"issue":"8","key":"9371_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","volume":"14","author":"F Apel","year":"2018","unstructured":"Apel F, Zychlinsky A, Kenny EF. The role of neutrophil extracellular traps in rheumatic diseases. Nat Rev Rheumatol. 2018;14(8):467\u201375.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"9371_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41584-019-0352-1","volume":"16","author":"G Wigerblad","year":"2020","unstructured":"Wigerblad G, Kaplan MJ. NETs spread ever wider in rheumatic diseases. Nat Rev Rheumatol. 2020;16(2):73\u20134.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"9371_CR25","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41467-019-09801-x","volume":"10","author":"RA Ali","year":"2019","unstructured":"Ali RA, Gandhi AA, Meng H, Yalavarthi S, Vreede AP, Estes SK, et al. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commun. 2019;10(1):1916.","journal-title":"Nat Commun"},{"issue":"11","key":"9371_CR26","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130(11):6151\u20137.","journal-title":"J Clin Invest"},{"issue":"10","key":"9371_CR27","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","volume":"129","author":"B McDonald","year":"2017","unstructured":"McDonald B, Davis RP, Kim SJ, Tse M, Esmon CT, Kolaczkowska E, et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood. 2017;129(10):1357\u201367.","journal-title":"Blood"},{"key":"9371_CR28","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.ebiom.2021.103382","volume":"67","author":"H Englert","year":"2021","unstructured":"Englert H, Rangaswamy C, Deppermann C, Sperhake JP, Krisp C, Schreier D, et al. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine. 2021;67:103382.","journal-title":"EBioMedicine"},{"issue":"20","key":"9371_CR29","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2018-10-862243","volume":"133","author":"DF Noubouossie","year":"2019","unstructured":"Noubouossie DF, Reeves BN, Strahl BD, Key NS. Neutrophils: Back in the thrombosis spotlight. Blood. 2019;133(20):2186\u201397.","journal-title":"Blood"},{"issue":"5","key":"9371_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, Vecchi\u00e9 A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319\u201329.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"9371_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41577-020-00429-3","volume":"20","author":"JS Lee","year":"2020","unstructured":"Lee JS, Shin EC. The type I interferon response in COVID-19: Implications for treatment. Nat Rev Immunol. 2020;20(10):585\u20136.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9371_CR32","doi-asserted-by":"publisher","first-page":"e000625","DOI":"10.1136\/lupus-2021-000625","volume":"9","author":"M Northcott","year":"2022","unstructured":"Northcott M, Jones S, Koelmeyer R, Bonin J, Vincent F, Kandane-Rathnayake R, et al. Type 1 interferon status in systemic lupus erythematosus: A longitudinal analysis. Lupus Sci Med. 2022;9(1):e000625.","journal-title":"Lupus Sci Med"},{"key":"9371_CR33","doi-asserted-by":"publisher","first-page":"657363","DOI":"10.3389\/fimmu.2021.657363","volume":"12","author":"RP da Silva","year":"2021","unstructured":"da Silva RP, Gon\u00e7alves JIB, Zanin RF, Schuch FB, de Souza APD. Circulating type I interferon levels and COVID-19 severity: A systematic review and meta-analysis. Front Immunol. 2021;12:657363.","journal-title":"Front Immunol"},{"issue":"12","key":"9371_CR34","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol. 2014;192(12):5459\u201368.","journal-title":"J Immunol"},{"issue":"10","key":"9371_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41584-020-0474-5","volume":"16","author":"JT Merrill","year":"2020","unstructured":"Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"9371_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fimmu.2016.00035","volume":"7","author":"A Mahajan","year":"2016","unstructured":"Mahajan A, Herrmann M, Mu\u00f1oz LE. Clearance deficiency and cell death pathways: A model for the pathogenesis of SLE. Front Immunol. 2016;7:35.","journal-title":"Front Immunol"},{"issue":"3","key":"9371_CR37","first-page":"227","volume":"52","author":"S Setiati","year":"2020","unstructured":"Setiati S, Harimurti K, Safitri ED, Ranakusuma RW, Saldi SRF, Azwar MK, et al. Risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients: A systematic review. Acta Med Indones. 2020;52(3):227\u201345.","journal-title":"Acta Med Indones"},{"key":"9371_CR38","doi-asserted-by":"crossref","unstructured":"Ziadi A, Hachimi A, Admou B, Hazime R, Brahim I, Douirek F, et al. Lymphopenia in critically ill COVID\u201019 patients: A predictor factor of severity and mortality. Int J Lab Hematol.\u00a02021;43(1):38\u201343.","DOI":"10.1111\/ijlh.13351"},{"key":"9371_CR39","doi-asserted-by":"crossref","unstructured":"Wang J, Li Q, Yin Y, Zhang Y, Cao Y, Lin X, et al. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Front Immunol. 2021;43(1):e38\u201346.","DOI":"10.2139\/ssrn.3611903"},{"key":"9371_CR40","doi-asserted-by":"publisher","first-page":"155302","DOI":"10.1016\/j.cyto.2020.155302","volume":"137","author":"H Sat\u0131\u015f","year":"2021","unstructured":"Sat\u0131\u015f H, \u00d6zger HS, Y\u0131ld\u0131z PA, H\u0131zel K, Gulbahar \u00d6, Erba\u015f G, et al. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19. Cytokine. 2021;137:155302.","journal-title":"Cytokine"},{"key":"9371_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijid.2020.09.1438","volume":"101","author":"M Vassallo","year":"2020","unstructured":"Vassallo M, Manni S, Pini P, Blanchouin E, Ticchioni M, Seitz-Polski B, et al. Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation. Int J Infect Dis. 2020;101:174\u20139.","journal-title":"Int J Infect Dis"},{"key":"9371_CR42","doi-asserted-by":"publisher","first-page":"102473","DOI":"10.1016\/j.jaut.2020.102473","volume":"112","author":"Y Sun","year":"2020","unstructured":"Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020;112:102473.","journal-title":"J Autoimmun"},{"issue":"4","key":"9371_CR43","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","volume":"20","author":"A Dotan","year":"2021","unstructured":"Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20(4):102792.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"9371_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155\u201362.","journal-title":"Curr Opin Rheumatol"},{"key":"9371_CR45","doi-asserted-by":"publisher","first-page":"100147","DOI":"10.1016\/j.jtauto.2022.100147","volume":"5","author":"JY Wang","year":"2022","unstructured":"Wang JY, Roehrl MW, Roehrl VB, Roehrl MH. A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases. J Transl Autoimmun. 2022;5:100147.","journal-title":"J Transl Autoimmun"},{"key":"9371_CR46","doi-asserted-by":"crossref","unstructured":"Wang JY, Zhang W, Roehrl VB, Roehrl MW, Roehrl MH. An autoantigen-ome from HS-sultan B-lymphoblasts offers a molecular map for investigating autoimmune sequelae of COVID-19. bioRxiv. 2021;3(12):24\u201333.","DOI":"10.1101\/2021.04.05.438500"},{"key":"9371_CR47","doi-asserted-by":"crossref","unstructured":"Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178):178ra40.","DOI":"10.1126\/scitranslmed.3005580"},{"key":"9371_CR48","doi-asserted-by":"crossref","unstructured":"Zuo Y, Yalavarthi S, Navaz SA, Hoy CK, Harbaugh A, Gockman K, et al. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight. 2021;6(15):12\u201323.","DOI":"10.1172\/jci.insight.150111"},{"key":"9371_CR49","doi-asserted-by":"crossref","unstructured":"Torres-Ruiz J, Absal\u00f3n-Aguilar A, Nu\u00f1ez-Aguirre M, P\u00e9rez-Fragoso A, Carrillo-V\u00e1zquez DA, Maravillas-Montero JL, et al. Neutrophil extracellular traps contribute to COVID-19 hyperinflammation and humoral autoimmunity. Cells. 2021;10(10):32\u201344.","DOI":"10.3390\/cells10102545"},{"issue":"2","key":"9371_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/cei.13623","volume":"205","author":"AG Richter","year":"2021","unstructured":"Richter AG, Shields AM, Karim A, Birch D, Faustini SE, Steadman L, et al. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol. 2021;205(2):99\u2013105.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"9371_CR51","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3201\/eid2607.200445","volume":"26","author":"M Jin","year":"2020","unstructured":"Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis. 2020;26(7):1618.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"9371_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-021-01023-9","volume":"23","author":"A Saud","year":"2021","unstructured":"Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and myositis: What we know so far. Curr Rheumatol Rep. 2021;23(8):1\u201316.","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"9371_CR53","first-page":"20","volume":"68","author":"Y Gokhale","year":"2020","unstructured":"Gokhale Y, Patankar A, Holla U, Shilke M, Kalekar L, Karnik ND, et al. Dermatomyositis during COVID-19 pandemic (a case series): Is there a cause effect relationship? J Assoc Physicians India. 2020;68(11):20\u20134.","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"9371_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jmii.2020.08.006","volume":"54","author":"S Pascolini","year":"2021","unstructured":"Pascolini S, Granito A, Muratori L, Lenzi M, Muratori P. Coronavirus disease associated immune thrombocytopenia: Causation or correlation? J Microbiol Immunol Infect. 2021;54(3):531.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"9371_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00277-020-04366-y","volume":"100","author":"MS Rahi","year":"2021","unstructured":"Rahi MS, Jindal V, Reyes S-P, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: A review. Ann Hematol. 2021;100(2):309\u201320.","journal-title":"Ann Hematol"},{"issue":"2","key":"9371_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1515\/revneuro-2020-0070","volume":"32","author":"P Nagu","year":"2021","unstructured":"Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: A comprehensive review. Rev Neurosci. 2021;32(2):219\u201334.","journal-title":"Rev Neurosci"},{"issue":"4","key":"9371_CR57","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11154-020-09615-z","volume":"22","author":"L Scappaticcio","year":"2021","unstructured":"Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: An update. Rev Endocr Metab Disord. 2021;22(4):803\u201315.","journal-title":"Rev Endocr Metab Disord"},{"key":"9371_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jocn.2021.05.065","volume":"90","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Scorza FA. Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients. J Clin Neurosci. 2021;90:140\u20133.","journal-title":"J Clin Neurosci"},{"key":"9371_CR59","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.nerep.2021.100008","volume":"1","author":"II Ismail","year":"2021","unstructured":"Ismail II, Al-Hashel J, Alroughani R, Ahmed SF. A case report of multiple sclerosis after COVID-19 infection: Causality or coincidence? Neuroimmunol Rep. 2021;1:100008.","journal-title":"Neuroimmunol Rep"},{"key":"9371_CR60","doi-asserted-by":"crossref","unstructured":"Ismail II, Al-Hashel J, Alroughani R, Ahmed SF. Association of multiple sclerosis and COVID-19 infection: A case report. MultScler Relat Disord. 2022;14(3):59\u201363.","DOI":"10.1016\/j.msard.2022.103608"},{"key":"9371_CR61","doi-asserted-by":"crossref","first-page":"232470962096119","DOI":"10.1177\/2324709620961198","volume":"8","author":"K Rajdev","year":"2020","unstructured":"Rajdev K, Victor N, Buckholtz ES, Hariharan P, Saeed MA, Hershberger DM, et al. A case of Guillain-Barr\u00e9 syndrome associated with COVID-19. J Investig Med High Impact Case Rep. 2020;8:2324709620961198.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"9371_CR62","doi-asserted-by":"crossref","first-page":"232470962096119","DOI":"10.1177\/2324709620961198","volume":"8","author":"K Rajdev","year":"2020","unstructured":"Rajdev K, Victor N, Buckholtz ES, Hariharan P, Saeed MA, Hershberger DM, et al. A case of Guillain-Barr\u00e9 syndrome associated with COVID-19. J Investig Med High Impact Case Rep. 2020;8:2324709620961198.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"9371_CR63","doi-asserted-by":"publisher","first-page":"102377","DOI":"10.1016\/j.msard.2020.102377","volume":"45","author":"M Palao","year":"2020","unstructured":"Palao M, Fern\u00e1ndez-D\u00edaz E, Gracia-Gil J, Romero-S\u00e1nchez C, D\u00edaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. 2020;45:102377.","journal-title":"Mult Scler Relat Disord"},{"key":"9371_CR64","doi-asserted-by":"crossref","unstructured":"Zhou S, Jones-Lopez EC, Soneji DJ, Azevedo CJ, Patel VR. Myelin oligodendrocyte glycoprotein antibody\u2013associated optic neuritis and myelitis in COVID-19.J Neuro-ophthalmol. 2020;12(2):23\u20139.","DOI":"10.1097\/WNO.0000000000001049"},{"issue":"8","key":"9371_CR65","doi-asserted-by":"publisher","first-page":"e244909","DOI":"10.1136\/bcr-2021-244909","volume":"14","author":"RS Knack","year":"2021","unstructured":"Knack RS, Hanada T, Knack RS, Mayr K. Hashimoto\u2019s thyroiditis following SARS-CoV-2 infection. BMJ Case Rep CP. 2021;14(8):e244909.","journal-title":"BMJ Case Rep CP"},{"issue":"10","key":"9371_CR66","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40618-020-01366-7","volume":"43","author":"M Mateu-Salat","year":"2020","unstructured":"Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: Report of two cases of Graves\u2019 disease after COVID-19. J Endocrinol Invest. 2020;43(10):1527\u20138.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"9371_CR67","doi-asserted-by":"publisher","first-page":"e14452","DOI":"10.1111\/ijcp.14452","volume":"75","author":"CM Trovato","year":"2021","unstructured":"Trovato CM, Montuori M, Pietropaoli N, Oliva S. COVID-19 and celiac disease: A pathogenetic hypothesis for a celiac outbreak. Int J Clin Pract. 2021;75(9):e14452.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"9371_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/ibd\/izaa221","volume":"27","author":"I Guerra","year":"2021","unstructured":"Guerra I, Algaba A, Jim\u00e9nez L, Mar Aller M, Garza D, Bonillo D, et al. Incidence, clinical characteristics, and evolution of SARS-CoV-2 infection in patients with inflammatory bowel disease: A single-center study in Madrid, Spain. Inflamm Bowel Dis. 2021;27(1):25\u201333.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"9371_CR69","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","volume":"75","author":"F Bril","year":"2021","unstructured":"Bril F, Al Diffalha S, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty? J Hepatol. 2021;75(1):222\u20134.","journal-title":"J Hepatol"},{"issue":"5","key":"9371_CR70","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jhep.2021.02.006","volume":"74","author":"A Bartoli","year":"2021","unstructured":"Bartoli A, Gitto S, Sighinolfi P, Cursaro C, Andreone P. Primary biliary cholangitis associated with SARS-CoV-2 infection. J Hepatol. 2021;74(5):1245\u20136.","journal-title":"J Hepatol"},{"issue":"7","key":"9371_CR71","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/1756-185X.14154","volume":"24","author":"K Masuko","year":"2021","unstructured":"Masuko K. Will the COVID-19 pandemic trigger future occurrence of autoimmunity like Sj\u00f6gren\u2019s syndrome? Int J Rheum Dis. 2021;24(7):963\u20135.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"9371_CR72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imm.13262","volume":"162","author":"SM Toor","year":"2021","unstructured":"Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology. 2021;162(1):30\u201343.","journal-title":"Immunology"},{"key":"9371_CR73","doi-asserted-by":"publisher","first-page":"624971","DOI":"10.3389\/fimmu.2020.624971","volume":"11","author":"T Koga","year":"2020","unstructured":"Koga T, Ichinose K, Kawakami A, Tsokos GC. Current insights and future prospects for targeting IL-17 to treat patients with systemic lupus erythematosus. Front Immunol. 2020;11:624971.","journal-title":"Front Immunol"},{"issue":"11","key":"9371_CR74","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1007\/s42399-020-00521-8","volume":"2","author":"S Bhattacharjee","year":"2020","unstructured":"Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: A systematic review. SN Compr Clin Med. 2020;2(11):2048\u201358.","journal-title":"SN Compr Clin Med"},{"issue":"9","key":"9371_CR75","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/cbin.11403","volume":"44","author":"N Fathi","year":"2020","unstructured":"Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020;44(9):1792\u20137.","journal-title":"Cell Biol Int"},{"key":"9371_CR76","doi-asserted-by":"crossref","unstructured":"Cavalcante-Silva LHA, Carvalho DCM, de Almeida Lima \u00c9, Galvao JG, da Silva JSdF, de Sales-Neto JM, et al. Neutrophils and COVID-19: The road so far. Int Immunopharmacol. 2021;90:107233.","DOI":"10.1016\/j.intimp.2020.107233"},{"issue":"9","key":"9371_CR77","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/jth.14975","volume":"18","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103\u20139.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"9371_CR78","doi-asserted-by":"publisher","first-page":"872","DOI":"10.7326\/L20-1298","volume":"174","author":"L Muhammed","year":"2021","unstructured":"Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK antibody-associated myasthenia gravis with SARS-CoV-2 infection: A case report. Ann Intern Med. 2021;174(6):872\u20133.","journal-title":"Ann Intern Med"},{"issue":"8","key":"9371_CR79","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/1756-185X.13909","volume":"23","author":"J Kabeerdoss","year":"2020","unstructured":"Kabeerdoss J, Danda D. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists? Int J Rheum Dis. 2020;23(8):998\u20131008.","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"9371_CR80","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1007\/s10067-020-05387-8","volume":"39","author":"AP Ladani","year":"2020","unstructured":"Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clin Rheumatol. 2020;39(11):3245\u201354.","journal-title":"Clin Rheumatol"},{"key":"9371_CR81","doi-asserted-by":"crossref","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: A systematic review and meta-analysis. Ann Rheum Dis. 2021;80(3):384\u201391.","DOI":"10.1136\/annrheumdis-2020-218946"},{"key":"9371_CR82","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/jrms.JRMS_331_20","volume":"25","author":"S Owlia","year":"2020","unstructured":"Owlia S, Owlia MB. Glucocorticoids in COVID19; a friend not foe. J Res Med Sci. 2020;25:45.","journal-title":"J Res Med Sci"},{"key":"9371_CR83","doi-asserted-by":"crossref","unstructured":"Cabanillas F, Morales J, Conde JG, Bertr\u00e1n-Pasarell J, Fern\u00e1ndez R, Hernandez-Silva Y, et al. Single-arm, open-label phase 2 trial of preemptive methylprednisolone to avert progression to respiratory failure in high-risk patients with COVID-19. medRxiv. 2021;23(4):33\u20139.","DOI":"10.1101\/2021.03.08.21253117"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-023-09371-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T08:05:29Z","timestamp":1692000329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-023-09371-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["9371"],"URL":"https:\/\/doi.org\/10.1007\/s12026-023-09371-7","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}